|
US7585622B1
(en)
*
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
|
US6777203B1
(en)
|
1997-11-19 |
2004-08-17 |
Geron Corporation |
Telomerase promoter driving expression of therapeutic gene sequences
|
|
US6261836B1
(en)
|
1996-10-01 |
2001-07-17 |
Geron Corporation |
Telomerase
|
|
US6093809A
(en)
|
1996-10-01 |
2000-07-25 |
University Technology Corporation |
Telomerase
|
|
GB2321642B8
(en)
*
|
1996-10-01 |
2006-08-22 |
Geron Corp |
Human telomerase reverse transcriptase promoter
|
|
US6610839B1
(en)
|
1997-08-14 |
2003-08-26 |
Geron Corporation |
Promoter for telomerase reverse transcriptase
|
|
US6808880B2
(en)
|
1996-10-01 |
2004-10-26 |
Geron Corporation |
Method for detecting polynucleotides encoding telomerase
|
|
US6475789B1
(en)
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
|
US7622549B2
(en)
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
|
CA2294782A1
(en)
*
|
1997-07-01 |
1999-01-14 |
Cambia Biosystems Llc |
Vertebrate telomerase genes and proteins and uses thereof
|
|
US7378244B2
(en)
|
1997-10-01 |
2008-05-27 |
Geron Corporation |
Telomerase promoters sequences for screening telomerase modulators
|
|
WO1999027113A1
(en)
*
|
1997-11-26 |
1999-06-03 |
Geron Corporation |
Mouse telomerase reverse transcriptase
|
|
US6608188B1
(en)
|
1998-01-08 |
2003-08-19 |
Chugai Seiyaku Kabushiki Kaisha |
CRT-1 gene having reverse transcriptase motif
|
|
US7402307B2
(en)
|
1998-03-31 |
2008-07-22 |
Geron Corporation |
Method for identifying and killing cancer cells
|
|
US6337200B1
(en)
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
|
JP2002509716A
(ja)
|
1998-03-31 |
2002-04-02 |
ユニバーシティ テクノロジー コーポレイション |
テロメラーゼ抗原に対する免疫応答を惹起するための方法および組成物
|
|
DE19916929A1
(de)
|
1999-04-15 |
2000-10-19 |
Bayer Ag |
Ein automatisierbarer Schnelltest zum Nachweis von Krebserkrankungen auf der Basis von Telomerase(hTC) mRNA mit spezifischen Primern und Sonden
|
|
US6912492B1
(en)
|
1999-05-25 |
2005-06-28 |
University Of Medicine & Dentistry Of New Jersey |
Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors
|
|
US6210950B1
(en)
*
|
1999-05-25 |
2001-04-03 |
University Of Medicine And Dentistry Of New Jersey |
Methods for diagnosing, preventing, and treating developmental disorders due to a combination of genetic and environmental factors
|
|
US6664046B1
(en)
|
1999-12-16 |
2003-12-16 |
Roche Molecular Systems, Inc. |
Quantitation of hTERT mRNA expression
|
|
KR20010096991A
(ko)
*
|
2000-04-19 |
2001-11-08 |
임정빈 |
텔로머레이즈의 프로모터에 특정하게 결합하는더블유티이1 절편, 그 유전자, 발현벡터 및 그것을 이용한세포성장 억제 방법
|
|
AUPQ923400A0
(en)
*
|
2000-08-07 |
2000-08-31 |
Children's Medical Research Institute |
Assays for alternative lengthening of telomeres
|
|
US7078491B1
(en)
|
2000-09-21 |
2006-07-18 |
Amgen Inc. |
Selective binding agents of telomerase
|
|
GB0031430D0
(en)
*
|
2000-12-22 |
2001-02-07 |
Norsk Hydro As |
Polypeptides
|
|
GB0112342D0
(en)
*
|
2001-05-21 |
2001-07-11 |
Norsk Hydro As |
Polypeptides
|
|
EP1440085B8
(de)
*
|
2001-10-18 |
2010-08-04 |
Medicyte GmbH |
Transiente immortalisierung von zellen durch onkogenproteine oder telomerproteine
|
|
WO2004053116A2
(de)
*
|
2002-12-06 |
2004-06-24 |
Technische Universität Dresden |
Gegen htert gerichtete polynucleotide und die verwendung dieser
|
|
EP1748067A1
(en)
*
|
2005-07-29 |
2007-01-31 |
Institut Pasteur |
Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof or polyepitopes
|
|
KR102511874B1
(ko)
*
|
2006-07-28 |
2023-03-20 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
개선된 백신 및 이의 사용 방법
|
|
EP1994942A1
(en)
*
|
2007-05-25 |
2008-11-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Pharmaceutical compositions comprising telomerase, and uses thereof
|
|
KR20130024888A
(ko)
|
2010-02-16 |
2013-03-08 |
오슬로 유니버시티 하스피탈 에이치에프 |
폴리펩티드
|
|
RU2468030C2
(ru)
|
2010-04-09 |
2012-11-27 |
Государственное учебно-научное учреждение Химический факультет Московского государственного университета им. М.В. Ломоносова |
Ингибиторы теломеразы и способ их получения
|
|
JP6267190B2
(ja)
|
2012-05-11 |
2018-01-24 |
ジェムバックス アンド カエル カンパニー，リミティド |
悪液質の予防用または治療用組成物
|
|
ES3046661T3
(en)
|
2012-05-11 |
2025-12-02 |
Gemvax & Kael Co Ltd |
Anti-inflammatory peptides and composition comprising the same
|
|
JP6272853B2
(ja)
|
2012-07-11 |
2018-01-31 |
ジェムバックス アンド カエル カンパニー，リミティド |
細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物
|
|
US20150125438A1
(en)
*
|
2012-07-20 |
2015-05-07 |
Sang Jae Kim |
Anti-Inflammatory Peptides and Composition Comprising the Same
|
|
CN107312759B
(zh)
*
|
2012-09-19 |
2025-10-28 |
珍白斯凯尔有限公司 |
细胞穿透肽、包含该肽的缀合物、及包含该缀合物的组合物
|
|
EP2970990B1
(en)
|
2013-03-15 |
2018-07-18 |
Monsanto Technology LLC |
Compositions and methods for the production and delivery of rna
|
|
KR102258864B1
(ko)
*
|
2013-04-19 |
2021-06-01 |
주식회사 젬백스앤카엘 |
허혈성 손상 치료 및 예방용 조성물
|
|
EP3004883B1
(en)
|
2013-06-07 |
2022-09-14 |
Gemvax & Kael Co., Ltd. |
Gv1001, gemcitabine and capecitabine for use in the treatment of pancreatic cancer in high eotaxin baseline level patients
|
|
JP6495899B2
(ja)
|
2013-06-21 |
2019-04-03 |
ジェムバックス アンド カエル カンパニー，リミティド |
ホルモン分泌調節剤、及びそれを含む組成物
|
|
KR102224965B1
(ko)
*
|
2013-07-12 |
2021-03-09 |
주식회사 젬백스앤카엘 |
세포 투과성 펩티드 및 이를 포함하는 컨쥬게이트
|
|
AU2014337805B2
(en)
|
2013-10-23 |
2018-03-15 |
Gemvax & Kael Co., Ltd. |
Composition for treating and preventing benign prostatic hyperplasia
|
|
KR102494803B1
(ko)
|
2013-11-22 |
2023-02-06 |
주식회사 젬백스앤카엘 |
혈관 신생 억제 활성을 가지는 펩티드 및 이를 포함하는 조성물
|
|
EP3085380B1
(en)
|
2013-12-17 |
2020-06-17 |
Gemvax & Kael Co., Ltd. |
Composition for treating prostate cancer
|
|
ES2908096T3
(es)
|
2014-04-11 |
2022-04-27 |
Gemvax & Kael Co Ltd |
Péptido con actividad inhibidora de la fibrosis y composición que lo contiene
|
|
CN106659149B
(zh)
|
2014-04-30 |
2020-05-19 |
珍白斯凯尔有限公司 |
用于器官、组织或细胞移植的组合物、试剂盒和移植方法
|
|
KR102413243B1
(ko)
|
2014-12-23 |
2022-06-27 |
주식회사 젬백스앤카엘 |
안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
|
|
JP6751097B2
(ja)
|
2015-02-27 |
2020-09-02 |
ジェムバックス アンド カエル カンパニー，リミティド |
聴力損傷予防用ペプチド及びそれを含む組成物
|
|
US11015179B2
(en)
|
2015-07-02 |
2021-05-25 |
Gemvax & Kael Co., Ltd. |
Peptide having anti-viral effect and composition containing same
|
|
WO2017070237A1
(en)
*
|
2015-10-19 |
2017-04-27 |
University Of Maryland, Baltimore |
Methods for generating engineered human primary blood dendritic cell lines
|
|
EP4272829A3
(en)
|
2016-04-07 |
2024-01-17 |
Gemvax & Kael Co., Ltd. |
Peptide having effects of increasing telomerase activity and extending telomere, and composition containing same
|
|
CN110117644A
(zh)
*
|
2019-04-18 |
2019-08-13 |
王金固 |
一种用于生物样本中rna的基因检测方法
|